Savant Capital, LLC Adma Biologics, Inc. Transaction History
Savant Capital, LLC
- $11.7 Billion
- Q3 2024
A detailed history of Savant Capital, LLC transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Savant Capital, LLC holds 13,701 shares of ADMA stock, worth $252,646. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,701
Previous 13,641
0.44%
Holding current value
$252,646
Previous $152,000
79.61%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding ADMA
# of Institutions
318Shares Held
184MCall Options Held
917KPut Options Held
91.6K-
Black Rock Inc. New York, NY18.6MShares$344 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.1MShares$334 Million0.01% of portfolio
-
State Street Corp Boston, MA13MShares$240 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA12.6MShares$233 Million0.05% of portfolio
-
Morgan Stanley New York, NY8.6MShares$159 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $3.62B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...